BCG, tuberculin skin-test results and asthma prevalence in school children in North London

Indian Pediatrics

Volumn 39, Issue 3, 2002, Pages 254-258

  Pahari, A ^a,b   Welch, S ^a   Lingam, S ^a  

^a ST ANN S HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Asthma; BCG vaccine; Tuberculin test

Indexed keywords

BCG VACCINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BCG VACCINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE; SCHOOL CHILD; SYMPTOMATOLOGY; TUBERCULIN TEST; UNITED KINGDOM; WHEEZING;

ADOLESCENT; ASTHMA; BCG VACCINE; CHILD; COUGH; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONDON; MALE; QUESTIONNAIRES; TUBERCULIN TEST;

EID: 0036130427     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G. Infection of mice with Mycobacterium bovis - Bacillus Calmette-Guerin suppresses allergen induced airway eosinophilia. J Exp Med 1998; 187: 561-569.
2. Cookson WOCM, Moffatt MF. Asthma: An epidemic in the absence of infection. Science 1997; 275: 41-42.
3. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275: 77-79.
4. Seaton A, Godden DJ, Brown K. Increase in asthma: A more toxic environment or a more susceptible population. Thorax 1994; 49: 171-174.
5. Von Mutius E, Fritzsch C, Weiland SK, Roell G, Magnussen H. Prevalence of asthma and allergic disorders among children in united Germany: A descriptive comparison. BMJ 1992; 305: 1395-1399.
6. Herz U, Gerhold K, Gruber C, Braun A, Wahn U, Renz H et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in animal model. J Allergy Clin Immunol 1998; 102: 867-875.
7. Alm JS, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy. Lancet 1997; 350: 400-403.
8. Gruber XC, Kulig M, Bergmann R, Guggenmoos-Holzmann I, Wahn U. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early BCG-vaccinated and nonvaccinated children. Pediatrics 2001; 107: e36.